Details of a Researcher - Okamura, Tomonori

Okamura, Tomonori

写真a

Affiliation: School of Medicine, Department of Preventive Medicine and Public Health (Shinanomachi)

Position: Professor

Related Websites

https://keiopublichealth.jp/index.html

External Links

Career 【 Display / hide 】

1988.04

Ministry of Health and Welfare, Japan
1988.04

-

1993.03

Kochi Prefectural Tosayamada Health Center
1993.04

-

2000.02

Osaka Medical Center for Cancer and Cardiovascular Diseases
2000.03

-

2007.07

Associate Professor, Department of Health Science, Shiga University of Medical Science
2002.10

-

2003.08

Department of Epidemiology and Public Health, Imperial College, London

Academic Background 【 Display / hide 】

1988.03

University of Tsukuba, School of Medicine

University, Graduated

Academic Degrees 【 Display / hide 】

MD,PhD, University of Tsukuba, Dissertation, 1996.02

Licenses and Qualifications 【 Display / hide 】

医師免許, 1988.05
日本医師会認定産業医, 1998.09
中央労働災害防止協会健康度測定研修修了医師, 1999.09
介護支援専門員, 2001.03
日本公衆衛生学会認定専門家, 2011.03

Research Areas 【 Display / hide 】

Life Science / Hygiene and public health (non-laboratory)
Preventive Medicine for cardiovascular disseases

Research Keywords 【 Display / hide 】

Preventive Medicine
Epidemiology and Public health
Dyslipidemia
Health Promotion
cardiovascular disease

Books 【 Display / hide 】

[日本の循環器病とその危険因子の動向] 循環器病予防エビデンスブック

岡村智教, 医歯薬出版株式会社 , 2020

Scope: 血清コレステロール値と脂質異常症の動向,, Contact page： 149-156 Original author：日本循環器病予防学会監修
【よくわかる】高血圧と循環器病の予防と管理(第二版)

岡村智教, （株）社会保険研究所, 2020

Scope: 家族性高コレステロール血症・その他の原発性脂質異常症., Contact page： 274-275 Original author：本高血圧学会,日本循環器病予防学会,日本動脈硬化学会,日本心臓病学会監修
第三期特定健診・特定保健指導ガイド(門脇孝、津下一代編）

Okamura Tomonori, 南山堂、東京, 2018.09

Scope: 冠動脈疾患（虚血性心疾患）発症予防からみた脂質管理．pp119-127
動脈硬化性疾患予防のための脂質異常症治療ガイド2018年版

Okamura Tomonori, （社）日本動脈硬化学会、東京, 2018
岸玲子監修、小泉昭夫、馬場園明、今中雄一、武林亨編．NEW予防医学・公衆衛生学.

Okamura Tomonori, 南江堂、東京, 2018

Scope: 第2章．疫学と方法, pp64-80

Papers 【 Display / hide 】

Genome-wide association study of plasma amino acids and Mendelian randomization for cardiometabolic traits.

Toki R, Fushiki S, Kojima S, Sutoh Y, Otsuka-Yamasaki Y, Harada S, Iida M, Hirata A, Miyagawa N, Matsumoto M, Edagawa S, Miyake A, Kuwabara K, Hirayama A, Sugimoto M, Sato A, Amano K, Soga T, Tomita M, Arakawa K, Kinoshita K, Sakurai-Yageta M, Tamiya G, Ohmomo H, Shimizu A, Okamura T, Takebayashi T

Scientific reports 15 ( 1 ) 14569 2025.04
- Access to Document (DOI)
A Randomized Clinical Trial of ICT-based Interventions for Sodium and Potassium Regulation in Healthy Adults.

Yano Y, Kitaoka K, Ohkubo T, Okamura T, Kanegae H, Yoshita K, Tsukinoki R, Okami Y, Node K, Rakugi H, Itoh H, Miura K

American journal of hypertension 2025.04

ISSN 0895-7061
- Access to Document (DOI)
Atherosclerotic Cardiovascular Disease Risk Prediction Models in China, Japan, and Korea: Implications for East Asians?

Nguyen P.K., Zhao D., Okamura T., Chang Kim H., Wong N.D., Yang E.

JACC: Asia 5 ( 3 ) 333 - 349 2025.03

　View Summary

The management of atherosclerotic cardiovascular disease (ASCVD) in the United States is currently based upon large epidemiological studies in primarily non-Hispanic White subjects. Although this strategy provides a uniform approach that is simpler to implement, it may result in inappropriately targeting certain Asian populations for treatment based on inaccurate ASCVD risk estimation. In this state-of-the-art review, we detail the similarities and differences in the prevalence of ASCVD and its risk factors among Chinese, Japanese, and Korean people living in the United States and in their native countries. We highlight the limitations of current risk calculators when applied to East Asian immigrants and summarize risk stratification approaches in China, Japan, and Korea. Our review underscores the need to disaggregate registry, cohort, and clinical trial data by East Asian subgroups, to actively engage these populations in research, and to initiate studies to better define ASCVD risk in East Asian people living in the United States.
- Access to Document (DOI)
All-Cause and Cause-Specific Mortality Associated with Long-Term Exposure to Fine Particulate Matter in Japan: The Ibaraki Prefectural Health Study

Michikawa, T; Nishiwaki, Y; Asakura, K; Okamura, T; Takebayashi, T; Hasegawa, S; Milojevic, A; Minami, M; Taguri, M; Takeuchi, A; Ueda, K; Sairenchi, T; Yamagishi, K; Iso, H; Irie, F; Nitta, H

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS 2025.01

ISSN 1340-3478
- Access to Document (DOI)
Comprehensive assessment of the impact of blood pressure, body mass index, smoking, and diabetes on healthy life expectancy in Japan: NIPPON DATA90.

Tsukinoki R, Murakami Y, Hayakawa T, Kadota A, Harada A, Kita Y, Okayama A, Miura K, Okamura T, Ueshima H

Journal of epidemiology 2025.01

ISSN 0917-5040
- Access to Document (DOI)

Papers, etc., Registered in KOARA 【 Display / hide 】

Development of risk prediction models for mild cognitive decline and frailty using metabolomics in a population-based cohort

Okamura, Tomonori

科学研究費補助金研究成果報告書 2022
Comparative study on arteriosclerotic index CAVI and urinary sodium-potassium ratio in different regions of Japan.

Okamura, Tomonori

科学研究費補助金研究成果報告書 2022
Assessment of quality of lipid parameters as a novel risk factor for cardiovascular diseases in community-based epidemiologic studies

Okamura, Tomonori

科学研究費補助金研究成果報告書 2020
Research on risk factors contributing to arteriosclerosis using CAVI in urban and remote islands

Okamura, Tomonori

科学研究費補助金研究成果報告書 2018
Metabolome-wide metabolic profiling and non-communicable disease prevention in a population-based cohort study

Okamura, Tomonori

科学研究費補助金研究成果報告書 2018

Reviews, Commentaries, etc. 【 Display / hide 】

Correction to: Universal health coverage in the context of population ageing: catastrophic health expenditure and unmet need for healthcare (Health Economics Review, (2024), 14, 1, (8), 10.1186/s13561-023-00475-2)

Okamoto S., Sata M., Rosenberg M., Nakagoshi N., Kamimura K., Komamura K., Kobayashi E., Sano J., Hirazawa Y., Okamura T., Iso H.

Health Economics Review 14 ( 1 ) 20 2024.12

ISSN 2191-1991

　View Summary

Correction to: Health Econ Rev 14, 8 (2024) Following the publication of the original article [1], the license copyright has been corrected to CC BY 3.0 IGO instead of Creative Commons Attribution 4.0 International License. The full correct copyright line should read as below: © World Health Organization 2024. Open Access This article is licensed under the terms of the Creative Commons Attribution 3.0 IGO License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the World Health Organization, provide a link to the Creative Commons licence and indicate if changes were made. The use of the World Health Organization’s name, and the use of the World Health Organization’s logo, shall be subject to a separate written licence agreement between the World Health Organization and the user and is not authorized as part of this CC-IGO licence. Note that the link provided below includes additional terms and conditions of the licence. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/3.0/igo/. Old Copyright Line: © World Health Organization 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. The original article [1] has been updated.
- Access to Document (DOI)
New Insights Into the Relation Between Metabolic Dysfunction Associated Fatty Liver Disease and Cardiovascular Disease

Hirata A., Okamura T.

JACC: Asia (JACC: Asia) 3 ( 6 ) 922 - 924 2023
- Access to Document (DOI)
Correction: Determinants of double product: a cross-sectional study of urban residents in Japan (Environ Health Prev Med (2023), 28, 37, 10.1265/ehpm.23-00002)

Nakagoshi N., Kubo S., Nishida Y., Kuwabara K., Hirata A., Sata M., Higashiyama A., Kubota Y., Hirata T., Tatsumi Y., Kawamura K., Miyazaki J., Miyamatsu N., Sugiyama D., Miyamoto Y., Okamura T.

Environmental Health and Preventive Medicine (Environmental Health and Preventive Medicine) 28 74 2023

ISSN 1342078X

　View Summary

After the publication of this article [1], it was discovered that there was a typo in one sentence of the discussion. Therefore, we will correct it as follows. On line 47 of the discussion, it says “This is equivalent to playing tennis for approximately 10 min daily or running for about 7–8 min daily.” This is corrected to “This is equivalent to playing tennis for approximately 1 hour daily or running for about 40 min daily.” Published online: 5 December 2023 References 1. Nakagoshi N, Kubo S, Nishida Y, Kuwabara K, Hirata A, Sata M, et al. Determinants of double product: a cross-sectional study of urban residents in Japan. Environ Health Prev Med. 2023;28:37. https://doi.org/10.1265/ehpm.23-00002. Environmental Health and Preventive Medicine Environmental Health and Preventive Medicine (2023) 28:74 https://doi.org/10.1265/ehpm.23-00220.
- Access to Document (DOI)
Serum modified high-density lipoprotein and risk of atherosclerotic cardiovascular disease in a Japanese community-based nested case-control study

Sata M., Kakino A., Hirata A., Iida M., Usami Y., Harada S., Fujita Y., Kohsaka S., Izawa Y., Sawano M., Oki K., Sugiyama D., Takahashi S., Takebayashi T., Sawamura T., Okamura T.

European Journal of Preventive Cardiology (European Journal of Preventive Cardiology) 29 ( 5 ) E193 - E195 2022.03

ISSN 20474873
- Access to Document (DOI)
Erratum: Development of a cardiovascular disease risk prediction model using the suita study, a population-based prospective cohort study in Japan (Journal of Atherosclerosis and Thrombosis, (2020) 27, 11, (1160-1175), 10.5551/jat.48843)

Nakai M., Watanabe M., Kokubo Y., Nishimura K., Higashiyama A., Takegami M., Nakao Y.M., Okamura T., Miyamoto Y.

Journal of Atherosclerosis and Thrombosis (Journal of Atherosclerosis and Thrombosis) 28 ( 3 ) 2021

ISSN 13403478

　View Summary

Incorrect Since CVD risk increases with age, categories for age were based on 10-year intervals up to age 60 years and 5-year intervals thereafter. Diabetes mellitus (DM) is defined as having a fasting blood glucose level of ≥ 126 mg/dL, currently using anti-diabetic medication, or both. Cigarette smoking was dichotomized as current versus other. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation . Non-HDL-C was calculated by subtracting HDL-C from TG. If the TG level was greater than 400 mg/dL, we set the value as missing (n =96). Correct Since CVD risk increases with age, categories for age were based on 10-year intervals up to age 60 years and 5-year intervals thereafter. Diabetes mellitus (DM) is defined as having a fasting blood glucose level of ≥ 126 mg/dL, currently using anti-diabetic medication, or both. Cigarette smoking was dichotomized as current versus other. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation . Non-HDL-C was calculated by subtracting HDL-C from TC. If the TG level was greater than 400 mg/dL, we set the value as missing (n=96). 27) 27)
- Access to Document (DOI)

Presentations 【 Display / hide 】

Clinical scores for atherosclerotic risk stratification in adults: strengths and limitations.

Okamura T.

WHF with National Member Session 7: International Atherosclerosis Society together with World Heart Federation. Japanese Circulation Society (JCS) together with World Congress of Cardiology (WCC) 2021. (Yokohama, Kanagawa) ,

2021.03
,
Symposium, workshop panel (nominated)
脳卒中・循環器病対策基本法による循環器病予防のこれから.

岡村智教．

シンポジウム．第56回日本循環器病予防学会.,

2020.12
,
Symposium, workshop panel (nominated)
脳卒中の早期受診・予防のための市民啓発の取り組み：地域介入の試み.

岡村智教.

第 34 回日本神経救急学会学術集会.,

2020.11
,
Oral presentation (invited, special)
EPOCH-JAPAN（Evidence for Cardiovascular Prevention from Observational Cohorts in Japan）から見た循環器疾患死亡の生涯リスク．

岡村智教．

シンポジウム．第52回日本動脈硬化学会総会.,

2020.07
,
Symposium, workshop panel (nominated)
脳卒中・循環器病の一次予防対策の現状と今後の課題．

岡村智教．

バイエル「心血管予防」スポンサードセミナー．第五回JCVA（日本心血管協会）学術集会,

2020.06
,
Symposium, workshop panel (nominated)

Research Projects of Competitive Funds, etc. 【 Display / hide 】

変性リポ蛋白を含む脂質プロフィールと脳・心血管疾患の関連、その規定要因の解明（基盤研究A 21H04854）

2021.04

-

Present

日本学術振興会, Research grant, Principal investigator
健康診査・保健指導における検診項目等の必要性、妥当性の検証、及び地域における検診実施体制の検討のための研究（厚生労働科学研究 19FA1008）

2019.04

-

Present

厚生労働省, 厚生労働科学研究費補助金, Research grant, Principal investigator
生涯にわたる循環器疾患の個人リスクおよび集団のリスク評価ツールの開発を目的とした大規模コホート統合研究（厚生労働科学研究 H29－循環器等－一般－003）

2017.04

-

2020.03

厚生労働省, 厚生労働科学研究費補助金, Research grant, Principal investigator
脂質異常症の質的な評価と動脈硬化性疾患の関連についての地域疫学研究（基盤研究B 16H05249）

2016.04

-

2021.03

日本学術振興会, Research grant, Principal investigator
循環器疾患における集団間の健康格差の実態把握とその対策を目的とした大規模コホート共同研究（厚生労働科学研究 H26-循環器等（生習）-一般-001）

2014.04

-

2017.03

厚生労働省, Research grant, Principal investigator

Works 【 Display / hide 】

生活習慣病予防のエビデンス（全24回）

Okamura Tomonori

2010.04

-

2012.03
,
Other, Single

Awards 【 Display / hide 】

日本動脈硬化学会五島雄一郎賞

Okamura Tomonori, 2013.07, 日本動脈硬化学会, A series of community-based cohort studies concerning the relationship between dyslipidemia and cardiovascular disease in Japanese populations

Type of Award： Award from Japanese society, conference, symposium, etc.
日本疫学会奨励賞

Okamura Tomonori, 2009.01, 日本疫学会, 日本人を対象とした脂質異常症の疫学研究

Type of Award： Award from Japanese society, conference, symposium, etc.
日本公衆衛生学会奨励賞

Okamura Tomonori, 2002.10, 日本公衆衛生学会, 老人保健事業を中心とした地域保健対策の評価と推進に関する研究

Type of Award： Award from Japanese society, conference, symposium, etc.
厚生統計研究奨励賞

Okamura Tomonori, 1998.12, 厚生統計協会, 循環器検診所見と高齢者（65～74歳）の生命予後、活動能力の関連についての追跡研究

Type of Award： Award from publisher, newspaper, foundation, etc.

Other 【 Display / hide 】

　View Details

先端医療センターコホート研究チーム　チームリーダー
　View Details

国立循環器病研究センター　客員部長
　View Details

滋賀医科大学　客員教授

Courses Taught 【 Display / hide 】

PUBLIC HEALTH 2 (ADVANCED)

2025
PUBLIC HEALTH 1 (BASIC)

2025
PREVENTIVE MEDICINE AND PUBLIC HEALTH: SEMINAR

2025
PREVENTIVE MEDICINE AND PUBLIC HEALTH: PRACTICE

2025
PREVENTIVE MEDICINE AND PUBLIC HEALTH

2025

Courses Previously Taught 【 Display / hide 】

Public Health

Keio University

2018.04

-

2019.03
,
Autumn Semester, Lecture, Within own ｆaculty, 110people
公衆衛生学

Keio University

2015.04

-

2016.03
,
Autumn Semester, Lecture, Within own ｆaculty
公衆衛生学

Keio University

2014.04

-

2015.03
,
Autumn Semester, Lecture, Within own ｆaculty
公衆衛生学

Keio University

2013.04

-

2014.03
,
Autumn Semester, Lecture, Within own ｆaculty
公衆衛生学

Keio University

2012.04

-

2013.03
,
Autumn Semester, Lecture, Within own ｆaculty

Social Activities 【 Display / hide 】

全国健康保険協会　理事（保健担当）

2017.10

-

Present
健康保険組合連合会データヘルス計画推進会議委員

2014.05

-

2017.03

Academic Activities 【 Display / hide 】

Journal of Atherosclerosis and Thrombosis, Editor in Chief

2022.07

-

Present
International Journal of Environmental Research and Public Health, Editorial board

2019.12

-

Present

Memberships in Academic Societies 【 Display / hide 】

Japan Atherosclerosis Society

　
Japan Epidemiological Association

　
Japanese Medical Society of Alcohol and Drug Studies

　
The Japanese Association for Cerebro-cardiovascular Disease Control（JACD）,

2022.07

-

Present
Japanese Society of Public Health,

2021.10

-

Present

Committee Experiences 【 Display / hide 】

2022.04

-

Present

健康増進に係る科学的な知見を踏まえた技術的事項に関するワーキング・グループ主査, 厚生労働省
2021.12

-

Present

第４期特定健診・特定保健指導の見直しに関する検討会座長代理, 厚生労働省
2021.10

-

Present

健康管理システム等標準化検討会座長, 厚生労働省
2020.04

-

Present

健康・医療・介護情報利活用検討会　健診等情報利活用ワーキンググループ, 厚生労働省
2015.02

-

Present

厚生科学審議会臨時委員（地域保健健康増進栄養部会）, 厚生労働省